| Original language | American English |
|---|---|
| Journal | Newsletter of LSHP |
| State | Published - Nov 2021 |
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Tepezza (teprotumumab-trbw), first FDA approved treatment for thyroid eye disease
- Lisa M. Lee
- , T Doan
- , Quetin Kelly
- , Shelby Brooks
- Virginia Tech
- University of Louisiana at Monroe
Research output: Contribution to journal › Article